Price
Frequently asked questions
What is Medios's market capitalization?
The market capitalization of Medios is $369.55M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Medios's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Medios is 25.99. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Medios?
Medios's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.558. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Medios's stock?
Currently, 7 analysts cover Medios's stock, with a consensus target price of $31.01. Analyst ratings provide insights into the stock's expected performance.
What is Medios's revenue over the trailing twelve months?
Over the trailing twelve months, Medios reported a revenue of $1.93B.
What is the EBITDA for Medios?
Medios's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $68.03M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Medios?
Medios has a free cash flow of $30.59M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
What is the 5-year beta of Medios's stock?
The 5-year beta for Medios is 0.98. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.
How many employees does Medios have, and what sector and industry does it belong to?
Medios employs approximately 1,000 people. It operates in the Health Care sector, specifically within the Major Drugs industry.
What is the free float of Medios's shares?
The free float of Medios is 23.57M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
Market Cap
$369.55M5Y beta
0.98EPS (TTM)
$0.558Free Float
23.57MP/E ratio (TTM)
25.99Revenue (TTM)
$1.93BEBITDA (TTM)
$68.03MFree Cashflow (TTM)
$30.59MPricing
1D span
$13.31$14.75
52W span
$14.56$20.14
Analyst Ratings
The price target is $31.01 and the stock is covered by 7 analysts.
Buy
7
Hold
0
Sell
0
Information
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
1,000
Major Drugs
Health Care
Identifier
ISIN
DE000A1MMCC8
Primary Ticker
ILM1